GOLDENWELL BIOTECH, INC. Proceeds from Contributed Capital
GOLDENWELL BIOTECH, INC. (GWLL) reported Proceeds from Contributed Capital of $0 for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-20.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromContributedCapital · last filed 2024-05-20
- GOLDENWELL BIOTECH, INC. proceeds from contributed capital for the quarter ending 2024-03-31 was $0.00.
- GOLDENWELL BIOTECH, INC. proceeds from contributed capital for the quarter ending 2023-06-30 was $0.00.
- GOLDENWELL BIOTECH, INC. proceeds from contributed capital for the quarter ending 2023-03-31 was $0.00.
- GOLDENWELL BIOTECH, INC. proceeds from contributed capital for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- GOLDENWELL BIOTECH, INC. proceeds from contributed capital for fiscal 2022 was $884.70K.
- GOLDENWELL BIOTECH, INC. proceeds from contributed capital for fiscal 2021 was $0.00.
| Period end | Proceeds from Contributed Capital 3 month | Proceeds from Contributed Capital 6 month | Proceeds from Contributed Capital 12 month |
|---|---|---|---|
| 2024-03-31 | $0.00 10-Q · filed 2024-05-20 | ||
| 2023-12-31 | $0.00 10-K · filed 2024-04-12 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-17 | $0.00 10-Q · filed 2023-08-17 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-19 | ||
| 2022-12-31 | $884.70K 10-K · filed 2024-04-12 | ||
| 2021-12-31 | $0.00 10-K · filed 2023-04-13 |